Read the docs
TI-2015-03343 Aliases CVE-2015-3957GHSA-7www-p5hq-f329

Hospira LifeCare PCA Infusion System before 7.0 stores private keys and certificates…

Priority LOW 22CWE-255Published · Updated

Key facts

Attack vector
Local
Privileges required
None
User interaction
— Not recorded in CVSS 2.0
Attack complexity
Low
Impact type
—
Confidentiality · integrity · availability
Partial · Partial · Partial
Fix status
No fix listed

Attack profile from CVSS 2.0 · NVD. Fix status from CNA.

Summary

Hospira LifeCare PCA Infusion System before 7.0 stores private keys and certificates, which has unspecified impact and attack vectors.

Why it matters now

EPSS 0.00544 45th percentileScored 2026-11-07
Fix No fix listed No fixed version in the sources yet

SSVC decision points

Not available: CISA has not published SSVC decision points for this record.

Affected products

VendorProductAffected versionsFixed inStatusSource
——all versions—No fix listedCNA
  • — Vendor— Affected all versions Fixed in — No fix listed CNA

CPE configurations NVD · 3

CPEVersionsRoleVendor
cpe:2.3:o:hospira:lifecare_pcainfusion_firmware:*:*:*:*:*:*:*:*up to 5.0VulnerableHospira
cpe:2.3:h:hospira:lifecare_pca3:-:*:*:*:*:*:*:*not specified by NVDVulnerableHospira
cpe:2.3:h:hospira:lifecare_pca5:-:*:*:*:*:*:*:*not specified by NVDVulnerableHospira
  • cpe:2.3:o:hospira:lifecare_pcainfusion_firmware:*:*:*:*:*:*:*:* Versions up to 5.0 Vulnerable ·Hospira
  • cpe:2.3:h:hospira:lifecare_pca3:-:*:*:*:*:*:*:* Versions not specified by NVD Vulnerable ·Hospira
  • cpe:2.3:h:hospira:lifecare_pca5:-:*:*:*:*:*:*:* Versions not specified by NVD Vulnerable ·Hospira

Remediation

No fixed version listed by the sources yet.

Timeline

  1. 2026-10-02 Threatist record created from CVE-2015-3957
  2. 2026-10-03 Alias added: GHSA-7www-p5hq-f329

References

Advisory 2

  • TI-2015-03050 The communication module on the Hospira LifeCare PCA Infusion System before 7.0 does not… CVSS 2.0HIGH 10.0

Sources

This product uses the NVD API but is not endorsed or certified by the NVD. Sources and licences